{"id":10514,"date":"2022-12-21T18:10:46","date_gmt":"2022-12-21T23:10:46","guid":{"rendered":"https:\/\/qprn.ca\/2022\/12\/des-mediateurs-inflammatoires-endogenes-contribuant-a-la-perte-de-tissu-nerveux\/"},"modified":"2024-06-18T09:52:33","modified_gmt":"2024-06-18T13:52:33","slug":"des-mediateurs-inflammatoires-endogenes-contribuant-a-la-perte-de-tissu-nerveux","status":"publish","type":"post","link":"https:\/\/qprn.ca\/en\/2022\/12\/21\/des-mediateurs-inflammatoires-endogenes-contribuant-a-la-perte-de-tissu-nerveux\/","title":{"rendered":"Endogenous inflammatory mediators contributing to nervous tissue loss"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Goal<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/qprn.ca\/en\/investigator\/steve-lacroix\/\">Steve Lacroix<\/a>\u2019s research team found that endogenous inflammatory mediators called interleukin (IL)-1\u03b1 is released by microglia after a spinal cord injury (SCI) and induces inflammation as well as oligodendrocytes\u2019 death. The team was thus interested in understanding how (IL)-1\u03b1 causes its toxic effects on myelin after SCI and what are the consequences.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Methodology<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Researchers first injected a recombinant form of IL-1\u03b1 in the cerebrospinal fluid of mice to study its effects on intact spinal cord. Then, genetically modified mice were created to invalidate the IL-1\u03b1 receptor, the IL-1R1, in cell populations specific to the spinal cord. IL-1\u03b1 was then injected in mice and the spinal cords were observed using different microscopy methods to see how cells responds in the absence of IL-1R1 in oligodendrocytes, microglia, astrocytes or endothelial cells. Along with observing the effects of IL-1\u03b1 on inflammation, cell activity and cell death in intact and injured spinal cord, studies of locomotor recovery post-SCI were performed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Main findings<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">IL-1\u03b1 administration to intact mice results in immune cell infiltration and spinal cord oligodendrocytes death, replicating some of the acute effects of SCI. Interestingly, dead oligodendrocytes were replaced within 3 to 5 days by new oligodendrocytes, which may be more capable of remyelination. IL-1\u03b1 or IL-1R1 invalidated mice recover more rapidly and more efficiently their locomotor function after SCI. Having demonstrated detrimental effects of IL-1\u03b1\/IL-1R1 signaling in the injured spinal cord, researchers therefore aimed to investigate the mechanism underlying inflammation and oligodendrocyte death. Using genetically modified mice, it was shown that IL-1\u03b1 effects on oligodendrocyte death are indirect. This death is partially caused by astrocytes, which are transformed into cells with toxic effects under IL-1\u03b1\u2019s influence. Indeed, these so-called toxic astrocytes release reactive chemicals called \u2018reactive oxygen species\u2019, which cause oligodendrocytes\u2019 death. It is also mediated by endothelial cells forming the spinal neurovasculature. Indeed, once stimulated by IL-1\u03b1, endothelial cells allow neutrophil infiltration and neuroinflammation. In both cases, IL-1\u03b1 receptor inactivation on the surface of astrocytes or endothelial cells greatly reduces oligodendrocytes\u2019 death.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Take home message<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">SCI affect millions of otherwise healthy men and women\u2019s lives, often without warning. It\u2019s obviously impossible to completely prevent such accidents and the primary damage they cause. However, a better understanding of the mechanisms underlying nerve tissue loss in the hours and days following the so-called primary injury, could allow a better control of secondary damage and thus limit the loss of function. This work shows that the release of IL-1\u03b1 after SCI stimulates astrocytes and endothelial cells to adopt toxic behaviors causing inflammation and oligodendrocyte death.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9527244\/pdf\/41467_2022_Article_33463.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Read more<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Goal Steve Lacroix\u2019s research team found that endogenous inflammatory mediators called interleukin (IL)-1\u03b1 is released&#8230;<\/p>\n","protected":false},"author":3,"featured_media":10510,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[69],"tags":[38],"class_list":["post-10514","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-popularized-publications","tag-articles-en"],"acf":[],"views":236,"_links":{"self":[{"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/posts\/10514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/comments?post=10514"}],"version-history":[{"count":0,"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/posts\/10514\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/media\/10510"}],"wp:attachment":[{"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/media?parent=10514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/categories?post=10514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qprn.ca\/en\/wp-json\/wp\/v2\/tags?post=10514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}